ArticleEnvironmental research2026
Associations between volatile organic compound mixtures and allostatic load: Evidence from the Green Heart Louisville Project.
Article in Environmental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Allostatic load (AL) represents the cumulative physiological burden from activation of adaptive response systems. High AL, resulting from multisystemic dysregulation after chronic activation of response systems, is associated with chronic disease risk. Volatile organic compound (VOC) exposure may contribute to this dysregulation, but the impact on AL is unclear. In this study, we evaluated the association between urinary VOC metabolites and AL in 959 adult participants of the Green Heart Louisville Project across four visits (2018 or 2019, 2021, 2022, 2023). We quantified AL using a Mahalanobis Distance-based index (AL-MD) derived from 15 biomarkers spanning cardiovascular, metabolic, immunoinflammatory, and neuroendocrine systems. In spot urine samples, we assessed seven metabolites of six parent VOCs (acrolein (3HPMA), 1,3-butadiene (34HBMA), N,N-dimethylformamide (MCaMA), ethylbenzene/styrene (PGA; MADA), and xylene (2MHA; 3MHA+4MHA)). Quantile-based g-computation was used to estimate the mixture effects on AL adjusting for covariates. A one quartile increase in this VOC metabolite mixture was associated with a 0.10 [0.02, 0.19] standard deviation higher AL-MD score. Effects were more pronounced in middle-aged (40-64 y/o; 0.15 [0.03, 0.26]) and older adults (65+ y/o; 0.14 [-0.06, 0.35]) compared with young adults (25-39 y/o; <0.01 [-0.13, 0.13]). This association was also stronger in males (0.15 [0.01, 0.29]) than females (0.07 [-0.04, 0.18]). Metabolites of acrolein, ethylbenzene/styrene, and xylene were consistent key drivers of physiological dysregulation. These findings suggest that VOC exposure could be a contributor to multisystemic dysregulation, as reflected by higher AL, providing a framework to detect environmental exposure-related subclinical effects linked to higher cardiovascular disease risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.